Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Quick Stats
May 18, 202657.5
AI Score
HOLD1.05
Volume Ratio
May 13, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
TNGX Stock Summary
Last updated May 18, 2026
TNGX is currently trading at $20.63, positioned above its 200-day moving average of $12.34, indicating a long-term uptrend. The stock has a 52-week range of $1.4 to $28.41.
Technical Analysis: The 50-day moving average stands at $21.75, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.205, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.052, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates TNGX at 57.5/100 with a HOLD recommendation.
TNGX (Tango Therapeutics, Inc.) Indicators
Last updated May 18, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 41.205 |
| CMF (20) | -0.052 |
| ROC (10) | -9.863 |
| ADX (14) | 28.188 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.125 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -82.423 |
| MFI (14) | 23.954 |
TNGX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TNGX Price vs Max Options Open Interest
TNGX Max Change In Options Open Interest
TNGX Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TNGX Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TNGX Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TNGX Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Tango Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
TNGX Moving Averages Analysis
Tango Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 18, 2026
TNGX (Tango Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated May 18, 2026
| Days | MA |
|---|---|
| 10 | 23.29 |
| 20 | 23.9 |
| 30 | 23.59 |
| 50 | 21.75 |
| 100 | 16.72 |
| 200 | 12.34 |
TNGX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.9 billion |
| Earnings/Share ($) | -0.83 |
| Net Proft Margin (%) | -1.8815 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.3286 |
| EPS Estimate Next Year ($) | -1.521 |
| WallStreet Target Price ($) | 31.6667 |
| Most Recent Quarter |